Company: IPCX
Filing Date: 2025-01-15
Form Type: CORRESP
Source: 0001213900-25-003975
Chunk: 1

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-01-15
Form: CORRESP
Chunk 1
---
ances 
 may result in a material dilution of the purchasers’ equity interests.                                                                |

: In response to the
Staff’s comment, the Company has revised the disclosure on pages 9-10 and 109 of Amendment No. 1.

| 3. | Please expand your disclosure in this section to include disclosure with respect to the consequences                                      
 to investors if you are required to wind down your operations as a result of investment company status, to include the loss of any        
 rights, which would expire worthless. Also, please confirm that if your facts and circumstances change over time, you will update your    
 disclosure to reflect how those changes impact the risk that you may be considered to be operating as an unregistered investment company. |

: In response to the
Staff’s comment, the Company has revised the disclosure on pages 55-56 of Amendment No. 1. The Company also confirms that if its
facts and circumstances change over time, it will update its disclosure to reflect how those changes impact the risk that it may be considered
to be operating as an unregistered investment company.

| 4. | We note numerous exceptions to the transfer restrictions in the table on page 110. Please add risk                                           
 factor disclosure about risks that may arise from the sponsor having the ability to remove itself as your sponsor before identifying a       
 business combination, including through the ability to transfer the founder shares or otherwise. Address the consequences of such removal    
 to the company’s ability to consummate an initial business combination, including that any replacement sponsor could have difficulty finding 
 a target.                                                                                                                                    |

: In response to the
Staff’s comment, the Company has revised the disclosure on pages 13, 84-85, 114 and 171 of Amendment No. 1.

| 5. | We note the disclosure on page 108 that each member of your management team owns, or will own,                                       
 directly or indirectly, interests in your sponsor. Please revise to discuss the membership interests in the sponsor that each member 
 of your management team will receive for their services to you. See Item 402(r)(3) of Regulation S-K.                                |

: In response to the
Staff’s comment, the Company has revised the disclosure on pages 8 and 109 of Amendment No. 1.

| 6. | Please disclose whether the interests in the sponsor, Inflection Point Fund I, LP or                             
 Inflection Point GP I LLC may be transferred to third parties. Please add risk factor disclosure, as applicable